These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3212599)

  • 1. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
    Heidrich H; Ranft J
    Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
    Heidrich VH; Baethke R; Beyer KH
    Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S
    Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
    Abendroth D; Sunder-Plassmann L
    Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocyte function in parenteral naftidrofuryl therapy].
    Janka HU; Rinninger F; Mehnert H
    Ther Ggw; 1982 Jul; 121(7):422-33. PubMed ID: 7051401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J; Heidrich H; Lammersen T
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
    Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
    Schmidt C; Royer RJ; Kissel P
    Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound].
    Weidinger P
    Med Welt; 1983 Apr; 34(17):531-4. PubMed ID: 6865725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
    Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
    [No Abstract]   [Full Text] [Related]  

  • 12. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
    Krupiński K; Bielawiec M; Szpak A; Płonowski A
    Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
    Rey JL; Quiret JC; Gamain J; Errasti M
    Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747
    [No Abstract]   [Full Text] [Related]  

  • 14. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of naftidrofuryl (praxilene) on the peripheral cerebral circulation. Dynamometric and dynamographic control].
    Barut C; Roch MT
    Bull Soc Ophtalmol Fr; 1974; 74(7-8):771-8. PubMed ID: 4469472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 17. Naftidrofuryl (Praxilene) in peripheral vascular disease.
    Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
    Jung F; Wolf S; Kiesewetter H
    Arzneimittelforschung; 1989 Oct; 39(10):1277-80. PubMed ID: 2610721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of femoral vasodilatator effects of naftidrofuryl and nicergoline on dog (author's transl)].
    Luong TN; Depin JC
    J Pharmacol; 1981; 12(3):263-75. PubMed ID: 7289623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
    Tan OT; Gaylarde PM; Sarkany I
    Australas J Dermatol; 1978 Aug; 19(2):51-3. PubMed ID: 728015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.